A double‐blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out‐patients.
Kenneth Davison, R. G. Farquharson, M. C. Khan, A. Majid
Abstract
Open-access reader
Kenneth Davison, R. G. Farquharson, M. C. Khan, A. Majid
Abstract
Open-access reader
In a double-blind 28-day comparison of alprazolam, diazepam and placebo, alprazolam 1.5-3 mg/day was of equivalent anxiolytic effect to 15-30 mg diazepam/day and there was some evidence of antidepressant activity by alprazolam, but not diazepam, in neurotic depression. No serious side-effects or laboratory abnormalities were encountered.
OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In a double-blind 28-day comparison of alprazolam, diazepam and placebo, alprazolam 1.5-3 mg/day was of equivalent anxiolytic effect to 15-30 mg diazepam/day and there was some evidence of antidepressant activity by alprazolam, but not diazepam, in neurotic depression. No serious side-effects or laboratory abnormalities were encountered.
Key concepts: Alprazolam, Diazepam, Placebo, Anxiolytic, Antidepressant, Neuroticism, Medicine, Double blind